Literature DB >> 27582516

Impact of Delays between Clinical and Laboratory Standards Institute and Food and Drug Administration Revisions of Interpretive Criteria for Carbapenem-Resistant Enterobacteriaceae.

Sarah M Bartsch1, Susan S Huang2, Kim F Wong3, Rachel B Slayton4, James A McKinnell5,6, Daniel F Sahm7, Krystyna Kazmierczak7, Leslie E Mueller1, John A Jernigan4, Bruce Y Lee8.   

Abstract

Delays often occur between CLSI and FDA revisions of antimicrobial interpretive criteria. Using our Regional Healthcare Ecosystem Analyst (RHEA) simulation model, we found that the 32-month delay in changing carbapenem-resistant Enterobacteriaceae (CRE) breakpoints might have resulted in 1,821 additional carriers in Orange County, CA, an outcome that could have been avoided by identifying CRE and initiating contact precautions. Policy makers should aim to minimize the delay in the adoption of new breakpoints for antimicrobials against emerging pathogens when containment of spread is paramount; delays of <1.5 years are ideal.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27582516      PMCID： PMC5078554          DOI： 10.1128/JCM.00635-16

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  28 in total

1.  The impact of gown-use requirement on hand hygiene compliance.

Authors:  Yoav Golan; Shira Doron; John Griffith; Hesham El Gamal; Maged Tanios; Keri Blunt; Laurie Barefoot; Judy Bloom; Katelyn Gamson; Laura K Snydman; Karen Hansjosten; Eldad Elnekave; Stanley A Nasraway; David R Snydman
Journal:  Clin Infect Dis       Date:  2005-12-28       Impact factor: 9.079

2.  Compliance with isolation precautions at a university hospital.

Authors:  David J Weber; Emily E Sickbert-Bennett; Vickie M Brown; Rebecca H Brooks; Irene P Kittrell; Brenda J Featherstone; Tina L Adams; William A Rutala
Journal:  Infect Control Hosp Epidemiol       Date:  2007-02-05       Impact factor: 3.254

3.  Editorial commentary: long-term acute care hospitals and carbapenem-resistant Enterobacteriaceae: a reservoir for transmission.

Authors:  Patricia Marquez; Dawn Terashita
Journal:  Clin Infect Dis       Date:  2013-08-14       Impact factor: 9.079

4.  Emerging Resistance, New Antimicrobial Agents  …  but No Tests! The Challenge of Antimicrobial Susceptibility Testing in the Current US Regulatory Landscape.

Authors:  R M Humphries; J A Hindler
Journal:  Clin Infect Dis       Date:  2016-03-29       Impact factor: 9.079

5.  Risk factors for colonization due to carbapenem-resistant Enterobacteriaceae among patients exposed to long-term acute care and acute care facilities.

Authors:  Ashish Bhargava; Kayoko Hayakawa; Ethan Silverman; Samran Haider; Krishna Chaitanya Alluri; Satya Datla; Sreelatha Diviti; Vamsi Kuchipudi; Kalyan Srinivas Muppavarapu; Paul R Lephart; Dror Marchaim; Keith S Kaye
Journal:  Infect Control Hosp Epidemiol       Date:  2014-04       Impact factor: 3.254

6.  Continuing Challenges for the Clinical Laboratory for Detection of Carbapenem-Resistant Enterobacteriaceae.

Authors:  Romney M Humphries; James A McKinnell
Journal:  J Clin Microbiol       Date:  2015-10-14       Impact factor: 5.948

7.  The potential regional impact of contact precaution use in nursing homes to control methicillin-resistant Staphylococcus aureus.

Authors:  Bruce Y Lee; Ashima Singh; Sarah M Bartsch; Kim F Wong; Diane S Kim; Taliser R Avery; Shawn T Brown; Courtney R Murphy; S Levent Yilmaz; Susan S Huang
Journal:  Infect Control Hosp Epidemiol       Date:  2012-12-18       Impact factor: 3.254

8.  Carbapenem-resistant Klebsiella pneumoniae in post-acute-care facilities in Israel.

Authors:  Debby Ben-David; Samira Masarwa; Shiri Navon-Venezia; Hagit Mishali; Ilan Fridental; Bina Rubinovitch; Gill Smollan; Yehuda Carmeli; Mitchell J Schwaber
Journal:  Infect Control Hosp Epidemiol       Date:  2011-09       Impact factor: 3.254

9.  Trends in susceptibility of Escherichia coli from intra-abdominal infections to ertapenem and comparators in the United States according to data from the SMART program, 2009 to 2013.

Authors:  Sibylle H Lob; Krystyna M Kazmierczak; Robert E Badal; Meredith A Hackel; Samuel K Bouchillon; Douglas J Biedenbach; Daniel F Sahm
Journal:  Antimicrob Agents Chemother       Date:  2015-03-23       Impact factor: 5.191

10.  The importance of long-term acute care hospitals in the regional epidemiology of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae.

Authors:  Michael Y Lin; Rosie D Lyles-Banks; Karen Lolans; David W Hines; Joel B Spear; Russell Petrak; William E Trick; Robert A Weinstein; Mary K Hayden
Journal:  Clin Infect Dis       Date:  2013-08-14       Impact factor: 9.079
View more
  16 in total

1.  High Prevalence of Multidrug-Resistant Organism Colonization in 28 Nursing Homes: An "Iceberg Effect".

Authors:  James A McKinnell; Loren G Miller; Raveena D Singh; Gabrielle Gussin; Ken Kleinman; Job Mendez; Bryn Laurner; Tabitha D Catuna; Lauren Heim; Raheeb Saavedra; James Felix; Crystal Torres; Justin Chang; Marlene Estevez; Joanna Mendez; Gregory Tchakalian; Leah Bloomfield; Sandra Ceja; Ryan Franco; Aaron Miner; Aura Hurtado; Ratharo Hean; Alex Varasteh; Philip A Robinson; Steven Park; Steven Tam; Thomas Tjoa; Jiayi He; Shalini Agrawal; Stacey Yamaguchi; Harold Custodio; Jenny Nguyen; Cassiana E Bittencourt; Kaye D Evans; Vincent Mor; Kevin McConeghy; Robert A Weinstein; Mary K Hayden; Nimalie D Stone; Karl Steinberg; Nancy Beecham; Jocelyn Montgomery; Walters DeAnn; Ellena M Peterson; Susan S Huang
Journal:  J Am Med Dir Assoc       Date:  2020-06-16       Impact factor: 4.669

2.  Public Health Efforts Can Impact Adoption of Current Susceptibility Breakpoints, but Closer Attention from Regulatory Bodies Is Needed.

Authors:  James A McKinnell; S Bhaurla; P Marquez-Sung; A Pucci; M Baron; T Kamali; J Bugante; B Schwartz; S Balter; D Terashita; S Butler-Wu; J Gunzenhauser; J Hindler; R M Humphries
Journal:  J Clin Microbiol       Date:  2019-02-27       Impact factor: 5.948

Review 3.  Understanding and Addressing CLSI Breakpoint Revisions: a Primer for Clinical Laboratories.

Authors:  Romney M Humphries; April N Abbott; Janet A Hindler
Journal:  J Clin Microbiol       Date:  2019-05-24       Impact factor: 5.948

Review 4.  Impact of 21st Century Cures Act on Breakpoints and Commercial Antimicrobial Susceptibility Test Systems: Progress and Pitfalls.

Authors:  Romney M Humphries; Mary Jane Ferraro; Janet A Hindler
Journal:  J Clin Microbiol       Date:  2018-04-25       Impact factor: 5.948

Review 5.  CLSI Methods Development and Standardization Working Group Best Practices for Evaluation of Antimicrobial Susceptibility Tests.

Authors:  Romney M Humphries; Jane Ambler; Stephanie L Mitchell; Mariana Castanheira; Tanis Dingle; Janet A Hindler; Laura Koeth; Katherine Sei
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

6.  Antibiotic Breakpoints: How Redefining Susceptibility Preserves Efficacy and Improves Patient Care.

Authors:  Mark Redell; Glenn Tillotson
Journal:  P T       Date:  2019-09

Review 7.  Don't Get Wound Up: Revised Fluoroquinolone Breakpoints for Enterobacteriaceae and Pseudomonas aeruginosa.

Authors:  Tam T Van; Emi Minejima; Chiao An Chiu; Susan M Butler-Wu
Journal:  J Clin Microbiol       Date:  2019-06-25       Impact factor: 5.948

8.  Use of Ancillary Carbapenemase Tests To Improve Specificity of Phenotypic Definitions for Carbapenemase-Producing Enterobacteriaceae.

Authors:  Shelley A Miller; Janet A Hindler; Angelo Chengcuenca; Romney M Humphries
Journal:  J Clin Microbiol       Date:  2017-03-29       Impact factor: 5.948

9.  Breakpoint beware: reliance on historical breakpoints for Enterobacteriaceae leads to discrepancies in interpretation of susceptibility testing for carbapenems and cephalosporins and gaps in detection of carbapenem-resistant organisms.

Authors:  Melanie L Yarbrough; Meghan A Wallace; Robert F Potter; Alaric W D'Souza; Gautam Dantas; Carey-Ann D Burnham
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-11-02       Impact factor: 3.267

10.  How Long-Term Acute Care Hospitals Can Play an Important Role in Controlling Carbapenem-Resistant Enterobacteriaceae in a Region: A Simulation Modeling Study.

Authors:  Bruce Y Lee; Sarah M Bartsch; Michael Y Lin; Lindsey Asti; Joel Welling; Leslie E Mueller; Jim Leonard; Shawn T Brown; Kruti Doshi; Sarah K Kemble; Elizabeth A Mitgang; Robert A Weinstein; William E Trick; Mary K Hayden
Journal:  Am J Epidemiol       Date:  2021-02-01       Impact factor: 4.897
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.